Genpact (NYSE: G) executive lines up new $229K stock sale

Rhea-AI Filing Summary

Genpact Limited (G) received a notice under Rule 144 that officer Anil Nanduru plans to sell 6,191 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $229,221.78. The shares relate to performance shares and are listed on the NYSE under CUSIP 168034407. In the prior three months, Nanduru reported additional sales of 11,852 shares for $401,972.43 on August 12, 2026 and 17,243 shares for $585,568.83 on August 11, 2026.

Key Figures

Planned shares to be sold: 6,191 shares Aggregate market value of planned sale: $229,221.78 Shares sold on August 12, 2026: 11,852 shares +3 more

6 metrics

Planned shares to be sold 6,191 shares Common stock to be sold under Rule 144 for account of Anil Nanduru

Aggregate market value of planned sale $229,221.78 Estimated aggregate market value for 6,191 Genpact common shares

Shares sold on August 12, 2026 11,852 shares Genpact common shares sold by Anil Nanduru

Proceeds on August 12, 2026 $401,972.43 Value of Genpact common stock sale on that date

Shares sold on August 11, 2026 17,243 shares Genpact common shares sold by Anil Nanduru

Proceeds on August 11, 2026 $585,568.83 Value of Genpact common stock sale on that date

Key Terms

Rule 144, Performance Shares, aggregate market value, CUSIP

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 01/10/2025 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"6191 | 229221.78 | 168034407 | 08/19/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

CUSIP financial

"6191 | 229221.78 | 168034407 | 08/19/2026"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

What insider sale is disclosed for Genpact Limited (G) in this Rule 144 notice?

Officer Anil Nanduru plans to sell 6,191 shares of Genpact Limited common stock under Rule 144, with an indicated aggregate market value of $229,221.78, through Morgan Stanley Smith Barney LLC on NYSE-listed shares.

Who is selling Genpact (G) shares and through which broker?

Officer Anil Nanduru is the person for whose account the Genpact shares are to be sold, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned Rule 144 transaction.

How many Genpact (G) shares has Anil Nanduru sold in the last three months?

In the last three months, Anil Nanduru reported selling 11,852 shares for $401,972.43 on August 12, 2026 and 17,243 shares for $585,568.83 on August 11, 2026, all Genpact common stock.

What is the value of the planned Genpact (G) share sale under Rule 144?

The planned Rule 144 sale covers 6,191 Genpact common shares with an aggregate market value of $229,221.78, based on the pricing information stated in the notice filed for the transaction.

What type of Genpact (G) securities are involved in this Rule 144 filing?

The filing involves common stock of Genpact Limited, related to performance shares, listed on the NYSE under CUSIP 168034407, with sales executed or planned under Rule 144 conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:09 PM Accepted by SEC EDGAR 08/19/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014966
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GENPACT LIMITED
SEC File Number	001-33626
Address of Issuer	Canon's Court 22 Victoria Street Hamilton BERMUDA HM 12
Phone	(441) 298 3300
Name of Person for Whose Account the Securities are To Be Sold	ANIL NANDURU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6191	229221.78	168034407	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2025	Performance Shares	Issuer			6191	01/10/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANIL NANDURU Canon's Court 22 Victoria Street Hamilton D0 HM 12	Common	08/12/2026	11852	401972.43
ANIL NANDURU Canon's Court 22 Victoria Street Hamilton D0 HM 12	Common	08/11/2026	17243	585568.83

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anil Nanduru
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)